ACHIEVEMENT OF COMPLETE REMISSION IS A STRONG PROGNOSTIC FACTOR IN 895 ELDERLY MYELOMA PATIENTS TREATED WITH MELPHALAN-PREDNISONE BASED-REGIMENS: RESULTS OF 3 MULTICENTER ITALIAN TRIALS

F. GAY;A. LAROCCA;MT PETRUCCI;P. MUSTO;AM LIBERATI;V. CALLEA;R. RIA;T. CARAVITA;C. CANGIALOSI;M. GRASSO;M. OFFIDANI;P. PREGNO;F. PATRIARCA;M. GALLI;M. CAVO;L. CATALANO;C. NOZZOLI;T. GUGLIELMELLI;R. ZAMBELLO;F. PISANI;V. MONTEFUSCO;F. ROSSINI;V. DE STEFANO;B. LUPO;DI RAIMONDO, FRANCESCO;G. GAIDANO;M. BOCCADORO;A. PALUMBO

2010-01-01